Related Experiment Video

Updated: Aug 29, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Rationale for the Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial

Denis Roy1

  • 1Research Center, Montreal Heart Institute, Montreal, Quebec, Canada. roy@icm.umontreal.ca

Cardiac Electrophysiology Review
|January 24, 2004
PubMed

Insights

This study compares rhythm versus rate control for patients with atrial fibrillation (AF) and congestive heart failure (CHF). Rhythm control may reduce cardiovascular mortality in these complex patients.

Area of Science:

  • Cardiology
  • Heart Failure Research
  • Atrial Fibrillation Management

Background:

  • Congestive heart failure (CHF) and atrial fibrillation (AF) frequently coexist, complicating patient management.
  • AF is an independent risk factor for mortality and morbidity in CHF patients.
  • Previous studies on AF and CHF lacked randomization and were often retrospective.

Purpose of the Study:

  • To compare the efficacy of rhythm control versus rate control strategies in patients with AF and CHF.
  • To evaluate the impact of these strategies on cardiovascular mortality.
  • To provide evidence-based guidance for managing coexisting AF and CHF.

Main Methods:

  • Prospective, multicenter randomized trial (AF-CHF).
  • 1450 CHF patients with left ventricular ejection fraction (LVEF) ≤35% and recent AF episode randomized.
  • Comparison of rhythm control strategy versus rate control strategy.

Main Results:

  • Anticipated 18.75% 2-year cardiovascular mortality in the rate control arm.
  • Anticipated 25% event reduction in the rhythm control group.
  • Enrollment nearing completion with ongoing follow-up.

Conclusions:

  • Rhythm control strategy may offer a survival benefit in patients with AF and CHF.
  • Further analysis of AF-CHF trial data is needed to confirm findings.
  • This trial addresses a critical gap in managing complex cardiovascular conditions.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...